| Symbol | TSX : AMB |
|---|---|
| Last trade | 0.025 |
| Volume | 750 |
| As of | 2010-03-08 15:44 EST |
| Note: Quotes are delayed. For informational purposes only. |
|
Shareholder information
Head Office
Ambrilia Biopharma Inc.
1010 Sherbrooke Street West, Suite 1800
Montreal, Quebec, H3A 2R7
Tel.: (514) 751-2003
Fax: (514) 751-2502
www.ambrilia.com
Stock Listing
Listing: Toronto Stock Exchange (TSX)
Symbol: AMB
Transfer Agent and Registrar
Computershare Investor Services
1500 University Street, 7th Floor
Montreal, Quebec H3A 3S8
Tel.: (514) 982-7888
Auditors
Ernst & Young LLP
Corporate Counsel
Fasken Martineau DuMoulin LLP
Annual and Special Meeting of Shareholders
The Annual and Special Meeting of Shareholders of Ambrilia will be held within a 3 month period following emergence of the company from protection under CCAA. The location of this meeting will be determined and announced at a later date.
Investor Information and Inquiries
Contact: Richard La Rue
Interim President & CEO
Tel.: (514) 751-2003 ex. 269
e-mail: rlarue@ambrilia.com
All filings for Ambrilia Biopharma Inc. are available through SEDAR.